Effects of Chronic Beta Receptor Stimulation on Glucose Metabolism

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Diabetes

• Publication date

  1984-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/diab.33.12.1144PMID 6094291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.

  2009cited by this paper
• Metabolic, circulatory and respiratory effects of a new sympathomimetic beta-receptor-stimulating agent, terbutaline, compared with those of orciprenaline.

  2009cited by this paper
• Effects of chronic beta-receptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones.

  1984cited by this paper
• Thyroid hormone action on intermediary metabolism

  1984cited by this paper
• Effects of Physical Training and Diet Therapy on Carbohydrate Metabolism in Patients with Glucose Intolerance and Non-insulin-dependent Diabetes Mellitus

  1984cited by this paper
• Calculation of substrate oxidation rates in vivo from gaseous exchange.

  1983cited by this paper
• The effect of thyroid hormones on gluconeogenesis and forearm metabolism in man.

  1983cited by this paper
• Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects.

  1982cited by this paper
• Relationship of beta-adrenoreceptor density to fitness in athletes.

  1982cited by this paper
• Adrenergic receptors in man

  1982cited by this paper
• Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations.

  1982cited by this paper
• Thermogenic response to insulin and glucose infusions in man: a model to evaluate the different components of the thermic effect of carbohydrate.

  1982cited by this paper
• Relationship of β-adrenoreceptor density to fitness in athletes

  1982cited by this paper
• Influence of hyperthyroidism on splanchnic exchange of glucose and gluconeogenic precursors.

  1981cited by this paper
• Enhanced Glucose Utilization During Prolonged Glucose Clamp Studies

  1981cited by this paper
• The effects of terbutaline on acid base, serum electrolytes, and glucose homeostasis during the management of preterm labor.

  1981cited by this paper
• Insulin resistance in uremia.

  1981cited by this paper
• The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization

  1981cited by this paper
• Insulin degradation by insulin target cells.

  1981cited by this paper
• Studies of the mechanism by which 3,5,3'- triiodothyronine stimulates 2-deoxyglucose uptake in rat thymocytes in vitro. Role of calcium and adenosine 3':5'-monophosphate.

  1981cited by this paper
• Role of Insulin in the Regulation of Protein Synthesis

  1980cited by this paper
• Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man.

  1980cited by this paper
• Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.

  1980cited by this paper
• Epinephrine-induced insulin resistance in man.

  1980cited by this paper
• The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man.

  1980cited by this paper
• Comparison of hormonal and metabolic effects of salbutamol infusion in normal subjects and insulin-requiring diabetics.

  1979cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Drug tolerance to beta2 adrenergic agents.

  1978cited by this paper
• Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.

  1978cited by this paper
• Norepinephrine: hormone and neurotransmitter in man.

  1978cited by this paper
• Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and patients with phaeochromocytoma: studies in vivo.

  1978cited by this paper
• A comparative evaluation of fenoterol and terbutaline in the treatment of asthma.

  1978cited by this paper
• Carbohydrate storage in man: speculations and some quantitative considerations.

  1978cited by this paper
• Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.

  1978cited by this paper
• Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange.

  1978cited by this paper
• Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy.

  1978cited by this paper
• The realiability of rates of glucose appearance in vivo calculated from constant tracer infusions.

  1978cited by this paper
• Workshop No. 4 : Drug Tolerance to Beta2 Adrenergic Agents

  1978cited by this paper
• Adrenergic desensitization in leukocytes of normal and asthmatic subjects.

  1977cited by this paper
• Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation.

  1977cited by this paper
• The immediate effect of a beta-adrenergic agonist (salbutamol) on carbohydrate and lipid metabolism during the third trimester of pregnancy.

  1977cited by this paper
• The effect of triiodothyronine on 2-deoxy-D-(1-3H)glucose uptake in cultured chick embryo heart cells.

  1977cited by this paper
• The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor function.

  1976cited by this paper
• Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

  1976cited by this paper
• The therapeutic value of oral long-term treatment with terbutaline (Bricanyl) in asthma. A follow-up study of its efficacy and side effects.

  1975cited by this paper
• EXPERIENCES OF LONGTERM TREATMENT OF ASTHMA WITH TERBUTALINE *

  1971cited by this paper
• Manual feedback technique for the control of blood glucose concentration

  1966cited by this paper
• INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT *

  1959cited by this paper
• The Elements of the Science of Nutrition

  year unknowncited by this paper

• Assessing clenbuterol’s modulation of metabolic and inflammatory pathways in Nile tilapia (Oreochromas niloticous) fed high fat diet

  2025cites this paper
• The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis

  2024cites this paper
• Role of G protein‐coupled receptor kinases (GRKs) in β2‐adrenoceptor‐mediated glucose uptake

  2024cites this paper
• Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial

  2023cites this paper
• Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines.

  2023cites this paper
• Hyperglycaemia and Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Physiological and molecular mechanisms of cold-induced improvements in glucose homeostasis in humans beyond brown adipose tissue

  2023cites this paper
• Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells

  2022cites this paper
• Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells

  2022cites this paper
• Improving skeletal muscle insulin sensitivity via beta2‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss

  2022cites this paper
• Muscle hypertrophic effect of inhaled beta2‐agonist is associated with augmented insulin‐stimulated whole‐body glucose disposal in young men

  2022influential citation
• Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity

  2020cites this paper
• &bgr; 2-Agonist Induces Net Leg Glucose Uptake and Free Fatty Acid Release at Rest but Not During Exercise in Young Men

  2018cites this paper
• Restricting mitochondrial GRK2 post-ischemia confers cardioprotection by reducing myocyte death and maintaining glucose oxidation

  2018cites this paper
• A potential role for mTORC1/2 in β2 adrenergic regulation of skeletal muscle glucose oxidation in models of intrauterine growth restriction

  2017cites this paper
• Enhanced insulin secretion and insulin sensitivity in young lambs with placental insufficiency-induced intrauterine growth restriction.

  2017cites this paper
• A potential role for mTORC 1 / 2 in β 2 adrenergic regulation of skeletal muscle glucose oxidation in models of intrauterine growth restriction

  2017cites this paper
• Ion channel gene expression as objective biomarkers of training induced fatigue

  2014cites this paper
• Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle.

  2011cites this paper
• Dopamine D1 and D2 Receptor Gene Expression and cGMP, IP3 and Ca2+ Regulation in the Brain Regions of Hypoxic Neonatal Rats: Role of Glucose, Oxygen and Epinephrine Supplementation

  2008cites this paper
• Effects of Adrenodemedullation on In Vivo Stimulated Glucose Utilization in Relation Rat Peripheral Tissue Insulin-to Glycolysis in

  2006cites this paper
• The acute effects of citrus aurantium extract on blood pressure and heart rate

  2006cites this paper
• Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake.

  2002cites this paper
• Effects of clenbuterol on insulin resistance in conscious obese Zucker rats.

  2001cites this paper
• Synthesis, Storage, and Secretion of Adrenal Medullary Hormones: Physiology and Pathophysiology

  2000cites this paper
• Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.

  1999cites this paper
• Current and potential drugs for treatment of obesity.

  1999cites this paper
• The beta-agonist cimaterol directly enhances chronic protein accretion in skeletal muscle.

  1998cites this paper
• Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.

  1998cites this paper
• Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog.

  1997cites this paper
• Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog.

  1997cites this paper
• 29. INSULIN AND BLOOD PRESSURE

  1996cites this paper
• Effects of beta-adrenergic blockade on insulin-mediated glucose disposal in hypertensive and normotensive rats.

  1996cites this paper
• Effects of oral albuterol on serum lipids and carbohydrate metabolism in healthy men.

  1996cites this paper
• Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism.

  1995cites this paper
• Glycogen synthase activity in two rat models of hypertension.

  1995cites this paper
• Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

  1995cites this paper
• Mutation of tyrosine‐141 inhibits insulin‐promoted tyrosine phosphorylation and increased responsiveness of the human beta 2‐adrenergic receptor.

  1995cites this paper
• Acute effects of central neuropeptide Y injection on glucose metabolism in fasted rats.

  1995cites this paper
• Acute noradrenergic activation induces insulin resistance in human skeletal muscle.

  1994cites this paper
• Insulin and Blood Pressure

  1994cites this paper
• New hypoglycaemic agents.

  1994cites this paper
• Treatment with a β-blocker with β2-agonism improves glucose and lipid metabolism in essential hypertension

  1994cites this paper
• Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension.

  1994cites this paper
• 25. INSULIN AND BLOOD PRESSURE

  1994cites this paper
• Prolonged administration of a β-agonist, salbutamol, to lambs does not impair metabolic or endocrine responses to the stress of dipping

  1993cites this paper
• Effects of adrenodemedullation on in vivo insulin-stimulated glucose utilization in relation to glycolysis in rat peripheral tissue.

  1993cites this paper
• Effects of terbutaline on basal thermogenesis of human skeletal muscle and Na-K pump after 1 week of oral use--a placebo controlled comparison with propranolol.

  1993cites this paper
• Effects of prolonged administration of a β-agonist drug, ritodrine, on cardiovascular, metabolic and endocrine responses to adrenaline in growing ram lambs

  1993cites this paper
• Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog.

  1993cites this paper
• Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism.

  1993cites this paper
• Beta 3 and atypical beta-adrenoceptors.

  1993cites this paper
• Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats.

  1993cites this paper
• Effects on Lipid and Glucose Metabolism of the Long-Acting β2-Adrenergic Drug Precursor Bambuterol in Patients with Non-Insulin-Dependent Diabetes Mellitus

  1993cites this paper
• β3 and Atypical β‐Adrenoceptors

  1993cites this paper
• Overview: Diabetes: New Chemical Entities

  1992cites this paper
• In vivo insulin action in genetic models of hypertension.

  1992cites this paper
• Increased insulin sensitivity in the high sodium one-kidney, one figure-8 hypertensive rat.

  1992cites this paper
• Chronic hyperinsulinemia decreases insulin action but not insulin sensitivity.

  1990cites this paper
• Intraportal hyperinsulinemia decreases insulin-stimulated glucose uptake in the dog.

  1990cites this paper
• Chapter 22. New Approaches to Diabetes

  1990cites this paper
• Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness.

  1990cites this paper
• Beta-adrenoceptors desensitization may modulate catecholamine induced insulin resistance in human pheochromocytoma.

  1989cites this paper
• Effects of BRL 35135, a beta-adrenoceptor agonist with novel selectivity, on glucose tolerance and insulin sensitivity in obese subjects.

  1989cites this paper
• Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure.

  1988cites this paper
• Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs.

  1988cites this paper
• Effect of high sucrose diet on insulin secretion and insulin action: a study in the normal rat

  1987cites this paper
• Hypoglycaemic agents which do not release insulin.

  1987cites this paper
• Obesity and thermogenesis in man.

  1987cites this paper
• Effects of prolonged elevation of plasma adrenaline concentration in vivo on insulin-sensitivity in soleus muscle of the rat.

  1987cites this paper
• Mechanism for enhanced glucose transport response to insulin in adipose cells from chronically hyperinsulinemic rats. Increased translocation of glucose transporters from an enlarged intracellular pool.

  1987cites this paper
• Cell Biology of Insulin's Stimulatory Action on Glucose Transport and Its Perturbation in Altered Metabolic States

  1986cites this paper
• Effects of beta non-selective and beta1 selective adrenergic blocking agents on glucagon secretion from isolated perfused rat pancreas

  1986cites this paper
• Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats.

  1985cites this paper